February 2, 2018February 2, 2018

FDA Approves Phase 3 Trial Plan for Prometic’s Pulmonary Fibrosis Therapy

The U.S. Food and Drug Administration has approved Prometic Life Sciences’ plan for a Phase 3 pivotal trial of its idiopathic pulmonary fibrosis therapy PBI-4050. PBI-4050 is an oral compound designed to ... Read more

January 31, 2018January 31, 2018

Singing for Lung Health Kicks Off in Bristol, UK

Idiopathic Pulmonary Fibrosis, News

Bristol is the most recent U.K. city hosting a Singing for Breathing group, called Singing for Lung Health, an initiative created to help anyone living with a lung condition as ... Read more

Posts by: Ana Pena

Ana Pena

FDA Approves Phase 3 Trial Plan for Prometic’s Pulmonary Fibrosis Therapy

Singing for Lung Health Kicks Off in Bristol, UK